标题
Clinical radioimmunotherapy—the role of radiobiology
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 8, Issue 12, Pages 720-734
出版商
Springer Nature
发表日期
2011-11-08
DOI
10.1038/nrclinonc.2011.160
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Radioimmunotherapy in follicular lymphoma
- (2011) Tim Illidge et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases
- (2011) A. S. Schulz et al. BLOOD
- Biodistribution and Dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in Patients with Metastatic Colorectal Adenocarcinoma
- (2011) Sui Shen et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
- (2011) Kwon Yong et al. DALTON TRANSACTIONS
- Cancer radioimmunotherapy
- (2011) Robert M Sharkey et al. Immunotherapy
- The Real Cost of Theoretic Risk Avoidance: The Need to Challenge Unsubstantiated Concerns About 131I Therapy
- (2011) S. J. Goldsmith JOURNAL OF NUCLEAR MEDICINE
- Radioimmunotherapy in Non-Hodgkin Lymphoma: Opinions of Nuclear Medicine Physicians and Radiation Oncologists
- (2011) N. G. Schaefer et al. JOURNAL OF NUCLEAR MEDICINE
- Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients
- (2010) M. F. Leahy et al. BLOOD
- Improved efficacy of α-particle-targeted radiation therapy
- (2010) Diane E. Milenic et al. CANCER
- Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas
- (2010) M. Corinna A. Palanca-Wessels et al. CANCER
- Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy
- (2010) Ludovic Ferrer et al. CANCER
- Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206
- (2010) Syed M. Abbas Rizvi et al. CANCER BIOLOGY & THERAPY
- Sequential Cytarabine and -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
- (2010) T. L. Rosenblat et al. CLINICAL CANCER RESEARCH
- A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin)
- (2010) Massimiliano Pacilio et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cyclophosphamide, Vincristine, and Prednisone Followed by Tositumomab and Iodine-131–Tositumomab in Patients With Untreated Low-Grade Follicular Lymphoma: Eight-Year Follow-Up of a Multicenter Phase II Study
- (2010) Brian K. Link et al. JOURNAL OF CLINICAL ONCOLOGY
- High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma
- (2010) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme
- (2010) Linna Li et al. JOURNAL OF NEUROSURGERY
- 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
- (2010) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of -Particle Emitters for Targeted Radionuclide Therapy
- (2010) G. Sgouros et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular and cellular radiobiological effects of Auger emitting radionuclides
- (2010) A. I. Kassis RADIATION PROTECTION DOSIMETRY
- Dose-rate effects in external beam radiotherapy redux
- (2010) C. Clifton Ling et al. RADIOTHERAPY AND ONCOLOGY
- Dose Intensified Molecular Targeted Radiotherapy for Cancer—Lymphoma as a Paradigm
- (2010) Gerald DeNardo et al. SEMINARS IN NUCLEAR MEDICINE
- Radioimmunotherapy of Lymphoma: Bexxar and Zevalin
- (2010) Stanley J. Goldsmith SEMINARS IN NUCLEAR MEDICINE
- Radiation-induced cell death mechanisms
- (2010) David Eriksson et al. TUMOR BIOLOGY
- Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2009) J. M. Pagel et al. BLOOD
- Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients
- (2009) S. Sauer et al. BLOOD
- A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy
- (2009) R. M. Sharkey et al. BLOOD
- Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I131KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
- (2009) Asma Sultana et al. BMC CANCER
- 188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning andin-vivoT cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation
- (2009) Anett Lauter et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Phase I Study of a Combination of Yttrium-90-Labeled Anti-Carcinoembryonic Antigen (CEA) Antibody and Gemcitabine in Patients with CEA-Producing Advanced Malignancies
- (2009) S. Shibata et al. CLINICAL CANCER RESEARCH
- A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas
- (2009) T. Meyer et al. CLINICAL CANCER RESEARCH
- Intraperitoneal -Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study
- (2009) H. Andersson et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy
- (2008) T. M. Illidge et al. BLOOD
- Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer
- (2008) M. Ychou et al. CLINICAL CANCER RESEARCH
- Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons
- (2008) M. Jules Mattes et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
- (2008) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation
- (2008) Liliana Devizzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma
- (2008) F. Buchegger et al. ONCOLOGIST
- Radioimmunotherapy-Based Conditioning Regimens for Stem Cell Transplantation
- (2008) Michelle M. Zhang et al. SEMINARS IN HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now